| Component | Supplier | Purity | Quantity (Phase 1) | |-----------|----------|--------|--------------------| | TiO₂ (P25) | Sigma‑Aldrich | 99.9 % | 500 g | | Silver nitrate (AgNO₃) | Alfa Aesar | 99.99 % | 250 g | | Cu₂ZnSnS₄ precursors | Nanophase | > 95 % | 300 g | | Gold chloride (HAuCl₄·3H₂O) | Sigma‑Aldrich | 99.9 % | 150 g | | Graphene oxide (GO) | Graphenea | 99 % | 100 g | | Solvents (IPA, ethanol, DMF) | Various | ACS grade | — |
In addition to scientific and technological interpretations, oksn-191 has also been examined within the context of cultural and historical phenomena. Some researchers have searched for connections to significant events, people, or places that might be associated with this enigmatic term.
| Parameter | Findings | |-----------|----------| | | > 2000 mg kg⁻¹ (no mortality) | | Repeated‑dose (28‑day, rat) | NOAEL = 150 mg kg⁻¹ day⁻¹; no clinically relevant changes in hematology, clinical chemistry, or organ histopathology | | Genotoxicity | Negative in Ames test (five strains) and in mouse micronucleus assay | | Cardiac safety | No hERG inhibition at 30 µM (IC₅₀ > 100 µM) | | Drug‑drug interaction | Moderate CYP3A4 inhibition (IC₅₀ ≈ 12 µM); low risk at therapeutic exposure (< 0.5 µM) | | Pregnancy & lactation | Embryo‑fetal development study in rats showed no teratogenicity at up to 30 mg kg⁻¹ day⁻¹ (≈ 2× therapeutic exposure) |
| Component | Supplier | Purity | Quantity (Phase 1) | |-----------|----------|--------|--------------------| | TiO₂ (P25) | Sigma‑Aldrich | 99.9 % | 500 g | | Silver nitrate (AgNO₃) | Alfa Aesar | 99.99 % | 250 g | | Cu₂ZnSnS₄ precursors | Nanophase | > 95 % | 300 g | | Gold chloride (HAuCl₄·3H₂O) | Sigma‑Aldrich | 99.9 % | 150 g | | Graphene oxide (GO) | Graphenea | 99 % | 100 g | | Solvents (IPA, ethanol, DMF) | Various | ACS grade | — |
In addition to scientific and technological interpretations, oksn-191 has also been examined within the context of cultural and historical phenomena. Some researchers have searched for connections to significant events, people, or places that might be associated with this enigmatic term. oksn-191
| Parameter | Findings | |-----------|----------| | | > 2000 mg kg⁻¹ (no mortality) | | Repeated‑dose (28‑day, rat) | NOAEL = 150 mg kg⁻¹ day⁻¹; no clinically relevant changes in hematology, clinical chemistry, or organ histopathology | | Genotoxicity | Negative in Ames test (five strains) and in mouse micronucleus assay | | Cardiac safety | No hERG inhibition at 30 µM (IC₅₀ > 100 µM) | | Drug‑drug interaction | Moderate CYP3A4 inhibition (IC₅₀ ≈ 12 µM); low risk at therapeutic exposure (< 0.5 µM) | | Pregnancy & lactation | Embryo‑fetal development study in rats showed no teratogenicity at up to 30 mg kg⁻¹ day⁻¹ (≈ 2× therapeutic exposure) | | Component | Supplier | Purity | Quantity
EN